All Type of News
Domestic pharmaceutical companies busy calculating profit and loss of the Chinese Yuan depreciation
As China dropped the value of Yuan drastically, domestic companies having business relationship with China have been busy calculating profit and loss lately.
According to the industry concern on the 11th, domestic ph...
Celltrion’s ‘Remsima’ acquired the Australian approvalCelltrion announced on the 10th that the company has acquired approval for Remsima from the Australian food and drug ministry, TGA(Therapeutic Goods Administration).
The TGA is...
|
‘Entecavir,’ a hepatitis type B treatment, became the target of priority sales for the 2nd time
A product approval for priority sales has been made for entecavir, a type B hepatitis treatment, which will be expired in substance approval on the coming October.
The Ministry of Food and Drug Safety has granted app...
Doctors quested if they would use generics of Baraclude soon expired in patent
The so-called ‘Big 5’ treatment market, expired in patent this year, has attracted the industry. Among the Big 5, the patent of Lilly’s Alimta was expired for the first time on May this year, and Pfizer’s ‘Celebrex’ a...
What would be the reason why DPP-4 competition is so fierce?Handok has announced the launch of ‘Tenelia(generic name: teneligliptin),’ the 7th DPP-4 inhibitor. Its insurance price was selected as the lowest among other DPP-4 inhibitors w...
|
New FDA-proved obesity drugs, ‘Belviq’ and ‘Contrave,’ entered the domestic market
In the domestic obesity treatment market which has been depressed after expulsion of sibutramine, a series of new obesity drugs have attracted attention of the market.
While Ildong Pharmaceutical has regularized mark...
Kwang Dong Pharmaceutical challenges to the obesity treatment market with the best selling drug ‘Contrave’Kwang Dong Pharmaceutical(President Sung-won Choi) will enter the obesity treatment market.
Kwang Dong Pharmaceutical announced on the 10th that it has established the domestic...
|
Thoughtless drug price reductions increase sales of purchased goods on domestic pharmaceutical companies
While the pharmaceutical industry has been opposed to drug price reduction caused by the research on the real transaction price of pharmaceutical products, it has been criticized that the continuous reduction encourag...
‘FocusMed,’ a combined sales CSO invested by Geo-Young, is founded
A CSO(Contract Sales Organization)-type company invested by both multinational and domestic distribution companies has been launched.
According to the industry concerned on the 10th, FocusMed Korea, a combined sales ...
“I concern that Nominee Jin-yup Jung may become a leader of medical commercialization”
At a confirmation hearing, the opposition party is expected to intensively review suspicion that Jin-yup Jung, a nominee for the Minister of Health and Welfare, has taken the ‘pre-medical commercialization, post-publi...
